This invention relates to the field of
biomedicine, specifically to the application of banana fruit extract in the preparation of
anticoagulant or
antithrombotic drugs. The banana fruit extract provided by this invention contains flavonoids, polyphenols, polysaccharides, hydroxyanthraquinones, triterpenoids, and other components. Flavonoids and polyphenols have been widely proven to have anti-inflammatory and
antioxidant effects, which can synergistically enhance the
anticoagulant effect. The high
potassium content of banana fruit can indirectly improve
vascular function by regulating
sodium-
potassium balance. The banana fruit extract provided by this invention can inhibit
platelet production or promote
platelet metabolism, prolong
clotting time, and inhibit
platelet aggregation. Its natural
plant components interfere with
platelet aggregation by inhibiting the production of
thromboxane A2, achieving
anticoagulant and
antithrombotic effects. The
mechanism of action of banana fruit extract differs from traditional anticoagulants such as
heparin, reducing the risk of bleeding. Its natural component characteristics provide a direction for the development of novel
plant-derived anticoagulant drugs.